Smart Money Alert

Dr. Lal Path Labs Ltd

IncreasedQuarterly

LALPATHLABHealthcareMarket Cap₹34K Cr

Stake

2.42% → 2.63%

Nippon India Mutual Fund

Mutual Fund

The move

Nippon India Mutual Fund increased its stake in Dr. Lal Path Labs Ltd from 2.42% to 2.63%, raising its shareholding from 4,046,700 to 4,415,617 shares. The additional 368,917 shares are valued at ₹62.68 crore based on the closing price of ₹1699.00 per share.

About Dr. Lal Path Labs Ltd

Visit stock

A leading diagnostic services provider in India, Dr. Lal PathLabs operates an integrated nationwide network delivering laboratory tests and comprehensive healthcare services. The company serves individual patients, hospitals, healthcare providers, and corporate clients through core diagnostic testing, disease diagnosis, prevention, monitoring, and treatment support. Its distinctive strength lies in combining consumer accessibility with a broad range of diagnostic capabilities and related health services across the country.

About Nippon India Mutual Fund

Visit investor

India's fifth-largest AMC with over Rs 6 lakh crore in AUM, backed by Japan's Nippon Life Insurance which holds majority stake. Formerly Reliance MF, rebranded in 2019 after Nippon's acquisition. Sailesh Raj Bhan has run the equity book for over two decades and is one of India's most experienced active managers. Known for sector rotational calls and a deep research bench.

Get the next move the moment it happens.

Follow Nippon India Mutual Fund and Dr. Lal Path Labs Ltd on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Dr. Lal Path Labs Ltd shareholders Nippon India Mutual Fund's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Dr. Lal Path Labs Ltd

Tata Mutual FundDecreased

Tata Mutual Fund sold 5,66,848 shares of Dr. Lal Path Labs Ltd, reducing its stake from 1.75% to 1.41% for approximately ₹108.21 Cr at ₹1,909 apiece.

11 Sept 2026

SBI Mutual FundExited

SBI Mutual Fund is no longer on Dr. Lal Path Labs Ltd's list of disclosed shareholders, after its last reported stake of 1.65 percent, indicating either a complete sale or a reduction below the 1 percent disclosure threshold.